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Abstract
Kainate receptors are a class of ionotropic glutamate receptors that have a role in the modulation of glutamate release and
synaptic plasticity in the hippocampal formation. Previous studies have implicated corticosteroids in the regulation of these
receptors and recent clinical work has shown that polymorphisms in kainate receptor subunit genes are associated with
susceptibility to major depression and response to anti-depressant treatment. In the present study we sought to examine
the effects of chronic stress and corticosteroid treatments upon the expression of the mRNA of kainate receptor subunits
GluR5-7 and KA1-2. Our results show that, after 7 days, adrenalectomy results in increased expression of hippocampal KA1,
GluR6 and GluR7 mRNAs, an effect which is reversed by treatment with corticosterone in the case of KA1 and GluR7 and by
aldosterone treatment in the case of GluR6. 21 days of chronic restraint stress (CRS) elevated the expression of the KA1
subunit, but had no effect on the expression of the other subunits. Similarly, 21 days of treatment with a moderate dose of
corticosterone also increased KA1 mRNA in the dentate gyrus, whereas a high corticosterone dose has no effect. Our results
suggest an interaction between hippocampal kainate receptor composition and the hypothalamic-pituitary-adrenal (HPA)
axis and show a selective chronic stress induced modulation of the KA1 subunit in the dentate gyrus and CA3 that has
implications for stress-induced adaptive structural plasticity.
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Introduction
The hippocampal formation, due to its high levels of expression of
receptors for corticosteroid stress hormones, is particularly suscep-
tible to weathering and structural changes as a resultofchronic stress
and stress related diseases such as depression. The interplay of
corticosteroids and ionotropic excitatory amino acid receptors in
producing structural and physiologic changes in the hippocampal
formation has been the subject of a significant amount of research,
but most of this research has focused upon NMDA and AMPA
receptors while relatively little has sought to describe the effects of
corticosteroids upon the expression of kainate receptors (KAR).
There are five members to the KAR gene family: GluR5, 6 and
7 and KA 1 and 2 [1] and kainate receptors are comprised of
various admixtures of the five subunit proteins produced by these
genes. The KARs contribute to both excitatory neurotransmission
and the presynaptic modulation of neurotransmitter release [2–4].
Notably, KAR activation contributes to LTP in the hippocampus,
particularly at the mossy fiber synapse of the CA3 [5].
A number of recent clinical studies have shown KARs have
potentially important roles in a number of major mental disorders,
particularly depression. Polymorphisms in the KA1 receptor have
been associated with response to the anti-depressant citalopram
and GluR6 has been associated with suicidal ideation during
treatment with the same drug [6,7]. The GluR7 gene has also
been connected to recurrent major depression [8]. KA1, GluR5
and GluR6 have also shown association with schizophrenia and
bipolar disorder [9,10].
The first study to examine the effects of corticosteroids upon
hippocampal KAR was performed by Clark and Cotman [11],
who tested the effects of adrenalectomy and corticosterone
(CORT) replacement on binding at AMPAR, KAR and
NMDAR and found no replicable effect of corticosterone or
adrenalectomy on
3H kainate binding. Watanabe [12], did
however, observe a decrease in
3H kainate binding after
adrenalectomy, an effect which was blocked by replacement
with the selective mineralocorticoid receptor (MR) agonist
aldosterone but not the glucocorticoid receptor (GR) selective
agonist RU28362. A study examining the expression of mRNA
for KAR subunits 3 days after adrenalectomy and in response to
acute high and low dose CORT showed that low doses of
CORT, which presumptively occupy only MR, increased
expression of all subunits, while ADX or high dose CORT
(occupying both MR and GR) failed to significantly alter
expression of any subunit [13]. Finally, chronic peripheral
administration of the GR agonist dexamethasone increases
expression of GluR6 protein in the dentate gyrus and CA3
[14]. To date these studies constitute most of what is known
about the interactions of corticosteroids and the KAR. The
present study aims to add to our understanding of these
interactions by examining the extent to which different kainate
receptor subunit mRNA’s are regulated differentially by stress
and adrenal steroids, using adrenalectomy, hormone replace-
ment, chronic restraint stress and chronic corticosterone
treatment of adrenally intact animals.
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Effects of adrenalectomy and adrenal steroid
replacement
In order to examine the effect of corticosteroids on the
expression of KAR subunits, we performed In situ hybridization
(ISH) after adrenalectomy and subacute treatment with cortico-
sterone, aldosterone and RU28362. ISH revealed KAR subunit
specific patterns of expression in the subfields of the hippocampal
formation, consistent with previous reports [15]. There was a
significant main effect of treatment (F (4,28)=3.824, see Figure 1.)
upon KA1 mRNA expression in the CA3 and dentate gyrus
regions of the dorsal hippocampus, but no main effects were seen
in the CA1 or CA2 regions. Adrenalectomy (ADX) increased KA1
message by 68611% in the CA3 and by 54613% in the dentate
(p,0.05 versus sham, n=8), while neither the selective MR
agonist aldosterone nor the selective GR agonist RU28362, given
alone, reversed this effect. However, treatment with corticosterone
significantly reduced KA1 mRNA from ADX levels (p,0.05),
suggesting that MR/GR heterodimers may regulate expression
specifically in the dentate gyrus and downstream in the CA3.
The GluR6 results, shown in Figure 2, suggest that this receptor
subtype is predominately regulated via MR in the DG, CA1 and
CA3. There was a main effect of treatment on GluR6 mRNA
expression in the CA1 (F (4,28)=3.778), CA3 (F (4,26)=2.991)
and dentate gyrus (F (4,26)=4.338) after corticosteroid manipu-
lations. In the DG, CA1 and CA3, ADX treatment showed a
modest but non-significant trend toward increased GluR6
expression, and ADX+Aldosterone treatment significantly reduced
mRNA compared to ADX treatment (p,0.05, n=8), with no
effect compared to sham. These data suggest that GluR6 mRNA is
predominantly regulated through MR in the dentate gyrus, CA1
and CA3.
For GluR7, there was a main effect of treatment on mRNA
expression in the dentate gyrus (F (4,32)=7.789, see Figure 3.).
Relative to Sham, ADX increased expression by 3965% (p,0.05)
and ADX+RU362 increased expression by 37.966% (p,0.05).
ADX+CORT replacement significantly reduced GluR7 message
levels from both ADX+Vehicle, ADX+Aldo, and ADX+RU362.
No main effects of treatment were observed with either GluR5
or KA2 after chronic corticosteroid manipulations (see Figure 4.
for representative autoradiograms of KA2 and GluR5 expression
in the hippocampal formation) .
Effects of chronic restraint stress
To examine the effects of a stress paradigm known to cause
structural and functional changes in the hippocampus on KAR
expression, KAR subunit levels were measured in the hippocam-
pus in response to 21-day chronic restraint stress (CRS).
Spironolactone, an MR antagonist, was used concurrently to
assess the possible contribution of MR to any stress effect. As can
be seen in Figure 5, a main effect of treatment was observed on
KA1 subunit expression in both the CA3 (F (2,21)=7.817) and
DG (F(2,21)=4.285). In the CA3, CRS and CRS+Spironolactone
significantly elevated expression compared to control. In the DG,
a similar increase was seen with CRS, but not with CRS+Spir-
onolactone. No other effects of CRS or CRS+Spironolactone were
seen with KA2, GluR5, GluR6, or GluR7. Final body weights of
both stressed groups (393.467.3g for CRS alone and 372.468.1g
for CRS and spironolactone) were significantly lower than controls
(430.266.6g, p,0.05), confirming that CRS was effective
systemically.
Effects of chronic corticosterone in drinking water
To confirm that the effects of CRS were corticosteroid
dependent, we treated rats for 21 days with vehicle, 25 mg/ml
Figure 1. ROD of KA1 mRNA in the dentate gyrus (A) and CA3 (B) after adrenalectomy and treatment with vehicle (ADX),
aldosterone (ADX+Aldo) RU28,362 (ADX+RU362) or corticosterone (ADX+CORT). (C) A representative autoradiogram of KA1 mRNA.
*-significantly different from sham and ADX+Cort (p,0.05, n=8). **-significantly different from ADX (p,0.05, n=8).
doi:10.1371/journal.pone.0004328.g001
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with a moderate dose of 25 mg/ml, but not a high dose of 400 mg/
ml of corticosterone significantly (p,0.05) increased KA1 mRNA
levels in the dentate gyrus (F (2,16)=6.504) but did not reach
significance in the CA3.
Apoptosis in the dentate gyrus
Adrenalectomy produced a 46% (p,0.00001) increase (from
3.2 to 4.8% of total cell profiles) in the number of pyknotic cells in
the dentate gyrus relative to sham adrenalectomized animals (data
not shown).
Figure 2. ROD of GluR6 mRNA in the dentate gyrus (A) CA3 (B) and CA1 (C) after adrenalectomy and treatment with vehicle (ADX),
aldosterone (ADX+Aldo) RU28,362 (ADX+RU362) or corticosterone (ADX+CORT). (D) A representative autoradiogram of GluR6 mRNA.
*-significantly different from sham and ADX+CORT (p,0.05, n=8).
doi:10.1371/journal.pone.0004328.g002
Figure 3. ROD of GluR7 mRNA in the dentate gyrus (A) after adrenalectomy and treatment with vehicle (ADX), aldosterone
(ADX+Aldo) RU28,362 (ADX+RU362) or corticosterone (ADX+CORT). (B) A representative autoradiogram of GluR6 mRNA. *-significantly
different from sham and ADX+CORT (p,0.05, n=8).
doi:10.1371/journal.pone.0004328.g003
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changes in expression of either of these transcripts.
doi:10.1371/journal.pone.0004328.g004
Figure 5. ROD of KA1 mRNA in the dentate gyrus (A) and CA3 (B) after CRS. *-significantly different from unstressed controls (p,0.05,
n=8).
doi:10.1371/journal.pone.0004328.g005
Figure 6. ROD of KA1 mRNA in the dentate gyrus (A) and CA3 (B) after 21 day treatment with either vehicle, 25 mg/ml or 400 mg/ml
corticosterone in drinking water. *-significantly different from vehicle treated animals (p,0.05, n=8).
doi:10.1371/journal.pone.0004328.g006
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Our studies reveal a complex pattern of changes in kainate
receptor subunit expression induced by adrenalectomy and cortico-
steroid replacement and a significant and somewhat paradoxical
effect of CRS and chronic corticosterone on KA1 mRNA levels, but
no effect of CRS upon either KA2 mRNA levels or levelsof GluR5-7
mRNA. This pattern, which was found in the dentate gyrus (DG)and
CA3 region of the hippocampal formation, demonstrates that CRS
involves more than adrenal steroid mediation and that increased
KA1 mRNA levels may help explain morphological changes caused
by CRS in the DG and CA3. Moreover, the results for KA1 mRNA
levels highlight the potential of adrenal steroids to oppose certain
actions of stress, which is analogous to their ability to inhibit
inflammatory cytokine production.
Effects of adrenalectomy and steroid replacement
The use of chronic adrenalectomy might have potentially
confounded the interpretation of our results as adrenalectomy can
produce apoptosis in dentate granule cells [16–18]. In our
experiment, adrenalectomy did increase the number of pyknotic
cells observed in the dentate gyrus, though the total percentage of
pyknotic cells was never higher than 5%. While we cannot exclude
d e n t a t ea p o p t o s i sa st h er e a s o nf o rt h ec h a n g ei nK A Rm R N Al e v e l s
we observe in that region, it seems an improbable explanation for a
number of reasons. First, the changes in mRNA levels we observed
after adrenalectomy were generally increases. Further, the changes
we saw in the dentate were mirrored in the CA3 (GluR6 and KA1)
and CA1 (KA1), suggesting that in these cases at least, the change is
morelikelyduetoadirecteffectofourmanipulationsofsteroidlevels,
rather than an indirect one due to cell death in the dentate gyrus.
GluR6 mRNA levels increased after adrenalectomy in all
regions of the hippocampus examined. This effect was reversed by
aldosterone treatment, but not by the specific glucocorticoid
receptor agonist, RU28362. This implicates the MR in the control
of GluR6 mRNA levels in the hippocampal formation. Joels [13],
also observed a non-significant increase in GluR6 in the DG after
3 days of adrenalectomy. Collectively, these observations suggest
that MR activation inhibits GluR6 expression within the
hippocampal formation.
KA1, but not KA2, mRNA expression also increased after
7 days of adrenalectomy, but the effect was reversed by high dose
corticosterone rather than either the MR or GR selective agonists.
GluR7 mRNA expression showed a similar pattern to KA1. We
observed no changes in KA2 or GluR5 though expression of the
latter was very low, which may have limited our ability to detect
subtle changes. That KA1 and GluR7 were regulated by
corticosterone but not by selective GR or MR agonists suggests
they may be regulated by MR/GR heterodimers, a permutation of
classical steroid receptor signaling recently described in cell culture
[19], but as yet undescribed in vivo.
Effects of chronic restraint stress
KA1 expression also increased after CRS; in fact, it was the only
KARsubunittodoso.ThisisinterestingbecauseKA1,incontrastto
KA2, appearstohave a largely pre-synapticlocalizationatthe mossy
fiber synapse [20]. Presynaptic KARs have been shown to act as
facilitating autoreceptors at the mossy fiber synapse [2,21–23].
These findings, therefore, suggest a potential mechanism for the
increase in hippocampal glutamate levels observed after stress
[24,25], namely, that they mediate a feed-forward enhancement of
glutamate release from mossy fiber terminals. Mossy fiber
activation by glutamate has been identified as a key factor in the
damaging effects of kainic acid on CA3 neurons [26–28].
Effects of chronic corticosterone treatment
Similarly to the effects of CRS, chronic treatment with a
moderate dose of corticosterone produced an elevation of KA1
mRNA in the dentate, similar to that produced by chronic
restraint stress. In the CA3, which has comparatively little GR
[29,30], this effect was not present, suggesting that the changes
observed in the CA3 with CRS are the result of other mediators of
the response to chronic stress, such as increased activity of the
glutamate system in the hippocampus [25] . Interestingly, the
response to chronic corticosterone showed an inverted-U shaped
dose response, an effect often seen with regard to the effects of
glucocorticoids on brain [31]. Chronic restraint, which produces a
moderate elevation of corticosterone levels similar to that
produced by our low dose treatment, but not as high as those
produced by the 400 mg/ml dose [32,33] fits with this interpre-
tation, as do the findings of Joels[13], who also found that KA1
mRNA expression was enhanced more by a lower dose of cort
than by a high dose. our results suggest that KA1 is also subject to
regulation by corticosteroids in an inverted U shaped fashion.
Adrenal steroids oppose effects of CRS in CA3 and
dentate gyrus
The role of adrenal steroids, at least based on the effects of
adrenalectomy and hormone replacement reported in this study, is
somewhat paradoxical and not unlike their anti-inflammatory
effects [34]. Moreover, the observation of increased KA1
expression in both adrenalectomy and CRS, however, is similar
to what has been observed for the glutamate transporter, GLT-1,
namely, an increased expression of GLT-1 after CRS but also an
increase after ADX that is reversed by adrenal steroid replacement
[35,36]. It is possible, for both GLT-1 and KA1, that two different
processes are operating in the two different treatment schemes.
One may speculate that, under basal conditions, adrenal
steroids may help to maintain the basal level of kainate receptors,
as well as GLT-1, so as to homeostatically regulate the level of
glutamate release and glutamatergic activity. According to the
present study, this type of regulation also applies to GluR6 and
GluR7, but not to GluR5 or KA2 mRNA expression. Yet, at the
same time, acute restraint stress elevates extracellular glutamate
levels, measured by microdialysis, and these elevations are blocked
by adrenalectomy [24]. Moreover, we show in the present study
that CRS produces a feed forward, allostatic up-regulation of the
KA1 subunit that may contribute to the dendritic retraction
caused by CRS, which is mediated in part by excitatory amino
acids [37]. Finally, our finding that moderate doses of CORT in
the drinking water mimic the CRS induced increase of KA1
mRNA levels whereas high oral doses of CORT fail to elevate
KA1mRNA indicates that a hormetic inverted U shaped dose
response is operating [38]. Moreover, this hormetic dose response
relationship may help explain the paradoxical finding that, while
both CRS and chronic CORT each separately cause shrinkage of
dendrites of CA3 neurons via a process dependent on glutamate
release, the combination of CRS plus chronic CORT treatment,
which presumptively elevates CORT levels beyond those pro-
duced by either treatment alone, prevented the dendritic
remodeling [39].
Future work, when specific antibodies become available, needs
to determine whether this up-regulation at the mRNA level is
reflected in increased KA1 protein expression (as subunit specific
radioligands are as yet unavailable), as well as determine the extent
to which stress-induced glucocorticoid secretion may be involved
in these changes. Examination of the behavior of KARs after
chronic stress using electrophysiology might also provide us with a
window on the functional role of these receptors in the adaptation
KAR, Stress & Steroids
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impaired by the lack of selective drugs. Another important
question to answer will be the extent to which chronic stress or
corticosteroid treatment alters the response of KARs to and acute
stressor or corticosteroid treatment, as this will allow us to begin to
assess the extent to which KARs are involved in resilience to stress
versus stress induced pathophysiology.
These findings are made more interesting by recent findings
associating KA1 and GluR6 and 7 with major depression and
other major mental disorders [6–10], all the more so because the
subunit which definitively did not change expression levels in our
experiments, KA2, has thus far shown no association with affective
disorders either. Further understanding of these changes could
permit an improved understanding of both stress induced
pathologies and the reasons why these pathologies can take a
substantial amount of time to reverse, as is the case with major
depression.
Methods
Animals
Adult male Sprague-Dawley rats were obtained from Charles
River Laboratories (Kingston, NY) at 70 days of age. Animals
were housed 2–3 per cage (same age cage mates) in clear
polycarbonate cages with wood chip bedding. All animals were
maintained on a 12 h light-dark schedule (lights on at 0800 h) and
the temperature was kept at 2162uC. All animals had ad libitum
access to food and water. All procedures were carried out in
accordance with the guidelines established by the NIH Guide for
the Care and Use of Laboratory Animals.
Chronic Restraint Stress
Animals were left undisturbed after arrival for one week after
delivery. Stressed animals were restrained in wire mesh restrainers,
secured at the head and tail ends with large binder clips. Chronic
stress was administered for 6 hours daily for 21 days from 10:00 to
16:00. Animals were returned to their home cages immediately
after termination of the stressor. These animals were sacrificed by
decapitation roughly 24 hours after the last stress (i.e. between
1300 and 1700 h). Brains were removed and flash frozen on dry
ice and then stored at 280uC until processing.
Steroid Treatments
These treatments follow those administered in [12] with some
modification. We chose to follow the one week time period used by
Watanabe for two reasons: first, he observed changes in KAR
levels after one week of steroid replacement. Secondly, after
adrenalectomy there is a progressive apoptosis of dentate gyrus
granule cells [16] and while we have successfully detected changes
in mRNA at the seven day time point in the past [12,40], we were
concerned that at later time points the potential for confounds
would be much greater. Animals were anesthetized using ketamine
and xylazine and the adrenal glands removed, save for one group
which received a sham surgery. During the same surgery, osmotic
mini-pumps (Alzet, Cupertino, CA) were implanted subcutane-
ously between the scapulae. These pumps delivered vehicle (50%
polyethylene glycol), the mineralocorticoid receptor agonist
aldosterone at 10 mg/hour or the glucocorticoid receptor agonist
RU28,362 at 10 mg/hour. Animals who underwent ADX received
0.9% saline in their drinking water and one group received
400 mg/ml corticosterone in addition to the saline. Seven days
after the completion of the surgeries, the animals were sacrificed
by decapitation and their brains removed and frozen as described
above.
Chronic Corticosterone Treatment
Animals were provided with either 2.5% ETOH (vehicle),
25 mg/ml corticosterone or 400 mg/ml corticosterone in their
home cage drinking water for a period of 21 days.
In Situ Hybridization
Brain sections were cut at 20 mm on a cryostat and placed on
Fisher Biotech ProbeOn Plus slides (Fisher, Pittsburgh, PA). In situ
hybridization began with a tailing reaction to radioactively label
the oligonucleotide probes with
35S. The probe sequences follow
those described by [41], two probe sequences were used in a
cocktail in order to improve sensitivity: KA1 59-TCC AGA GAG
GAG AAA TAG CCC GGT CTG CGT CCC ATA TGA ACT
CTG -39,5 9-CTT GTA GTT GAA CCG TAG GAT CTC AGC
GAA CTC CTT GAG CAT GTC-39; KA2 59-TTC CAC TCG
GGC CTT GGC TGG GAC CTC GAT GAT CCC ATT GAT
CTG-39,5 9-GTT CTC CAG GAT ATG GGG ACG CGC CCG
AAG ACA CGG GTG AGG GTT-39; GluR5 59-AAA TCC
CTC CGA TCC TGA GCA CT TGA GGG GAG GTC TGA
GGG AGG-39,5 9-CCC GGG TTG GTT CCA TTG GGC TTC
CGC GTA AAG GAT GCT AAT GCC-39; GluR6 59-GGT
TCC TTG CGA ATA TCC GAT CCA CAA TAA GCA GAG
CAG G, 59- GGT TCC TTG CGA ATA TCC GAT CCA CAA
TAA GCA GAG CAG G-39,5 9-ACT AAA CCT GGC TAT
GAC AAA GAG CAC ACA ACT GAC ACC CAA GTA-39;
GluR7 59-CTC AGC GTT CAT GAC CTG GGC GTT GGG
GCC GTC CGC GTA CTC AAA-39,5 9-ATT CTC CAC CAC
CTC AGA GCC GGG GTT GCA GGG GTG GGC ATC
ATA-39. Processing of the slides followed methods as previously
described in [42]. Anatomical locations were determined with the
assistance of the atlas of Paxinos and Watson [43]. Optical density
was determined using MCID 5.0 (Imaging Research, St.
Catharine’s, OT, Canada).
Pyknotic Cell Counts
Numbers of pyknotic cells were assessed following the method
of Frye and McCormick [44]. Sections were serial to those used
for autoradiography and in situ. Slides containing these sections
were processed to reveal Nissl substance beginning with a brief
fixation in 4% paraformaldehyde in 0.1M PB for 15 minutes
after which they were washed in distilled water three times for
2 minutes per wash. Sections were then dipped in 0.1% Cresyl
Violet for 2 minutes and then dehydrated in ascending
concentrations of ethanol prior to clearing in xylenes for
4 minutes. After drying, the slides were coverslipped with
permount. Pyknotic cells in the granule cell layer and subgranule
zone of the dentate gyrus were identified in a 1006visual field as
those having a small volume, membrane blebbing, and dark
condensed nucleus and chromatin.
Statistics
Optical density measurements were analyzed by a one way
ANOVA for the chronic steroid study and the chronic stress study.
Significant main effects and interactions in ANOVA were further
analyzed using Fisher’s protected least significant difference test
and Tukey’s test, respectively. Differences are considered signif-
icant at p,0.05. All data are presented as mean6SEM.
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